VPS4A and neoplasm: To further explore whether ALO exhibits therapeutic effects on NSCLC tumor growth in vivo through targeting VPS4A, WT and VPS4A KO H1299 cells were subcutaneously injected into nude mice to establish a subcutaneous tumor model (Figure 7D).